Research map: Clinical and genetic risk factors for anthracycline‑induced cardiotoxicity in Chinese early‑stage breast cancer patients: a candidate gene study

Back to the article

Papers in this map

  1. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin · DavidA Gewirtz · 1999 · 2264 citations · Cited by this paper
  2. Real-world effectiveness of pembrolizumab for first-line treatment of metastatic non-small-cell lung cancer: a decade of evidence and experience · Riddhi A. Babel · 2026 · Related
  3. Doxorubicin-Induced Cardiomyopathy · Pawan K. Singal · 1998 · 1863 citations · Cited by this paper
  4. Smoldering multiple myeloma: a multi-country mixed-methods study on disease perceptions and patient treatment preferences · 2026 · Related
  5. Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer · Aman U. Buzdar · 2005 · 1174 citations · Cited by this paper
  6. Enzalutamide in biochemically recurrent prostate cancer: key findings from subsequent analyses of EMBARK and their implications in clinical practice · 2026 · Related
  7. Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition · Daniela Maria Cardinale · 2006 · 1032 citations · Cited by this paper
  8. Study of brentuximab vedotin combination treatment in people with early-stage Hodgkin lymphoma: a plain language summary · 2026 · Related
  9. Anthracycline Cardiotoxicity: Prevalence, Pathogenesis and Treatment · М. И. Волкова · 2012 · 890 citations · Cited by this paper
  10. IGNITE: a phase III study of tirabrutinib versus rituximab and temozolomide combination therapy in relapsed/refractory primary central nervous system lymphoma · 2026 · Related
  11. Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention · Adriana Albini · 2009 · 849 citations · Cited by this paper
  12. Real-world comparative effectiveness of first-line BTK inhibitors in chronic lymphocytic leukemia · 2026 · Related
  13. Molecular Cloning, Characterization, and Expression in Escherichia coli of Full-length cDNAs of Three Human Glutathione S-Transferase Pi Gene Variants · Francis R. Ali-Osman · 1997 · 721 citations · Cited by this paper
  14. Sacituzumab govitecan in colorectal cancer: clinical evidence and future directions · 2026 · Related
  15. NAD(P)H Oxidase and Multidrug Resistance Protein Genetic Polymorphisms Are Associated With Doxorubicin-Induced Cardiotoxicity · Leszek Wojnowski · 2005 · 490 citations · Cited by this paper
  16. A plain language summary of the final overall survival results from the TALAPRO-2 study comparing talazoparib plus enzalutamide with placebo plus enzalutamide for patients with advanced prostate cancer · 2026 · Related
  17. Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children · Henk Visscher · 2011 · 404 citations · Cited by this paper
  18. Treatment outcomes with palbociclib plus an aromatase inhibitor in patients with metastatic breast cancer who also have cardiovascular diseases: a plain language summary · 2026 · Related
  19. Review and Meta-Analysis of Incidence and Clinical Predictors of Anthracycline Cardiotoxicity · Marzia Lotrionte · 2013 · 379 citations · Cited by this paper
  20. A Naples prognostic score-based nomogram enhances perioperative risk stratification for resected pancreatic cancer · 2026 · Related
  21. Anthracycline-Related Cardiomyopathy After Childhood Cancer: Role of Polymorphisms in Carbonyl Reductase Genes—A Report From the Children's Oncology Group · Javier G. Blanco · 2011 · 372 citations · Cited by this paper
  22. Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management · Elly V. Barry · 2007 · 312 citations · Cited by this paper
  23. A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer · Folefac Aminkeng · 2015 · 283 citations · Cited by this paper
  24. Recommendations for genetic testing to reduce the incidence of anthracycline‐induced cardiotoxicity · Folefac Aminkeng · 2016 · 238 citations · Cited by this paper
  25. Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:quinone oxidoreductase 1 gene NQO1 in patients who developed anthracycline‐related congestive heart failure after childhood cancer · Javier G. Blanco · 2008 · 221 citations · Cited by this paper
  26. Validation of variants inSLC28A3andUGT1A6as genetic markers predictive of anthracycline‐induced cardiotoxicity in children · Henk Visscher · 2013 · 201 citations · Cited by this paper
  27. Decline in the Use of Anthracyclines for Breast Cancer · Sharon Hermes Giordano · 2012 · 195 citations · Cited by this paper
  28. Hyaluronan Synthase 3 Variant and Anthracycline-Related Cardiomyopathy: A Report From the Children's Oncology Group · Xuexia Wang · 2014 · 162 citations · Cited by this paper
  29. Predicting and Preventing Anthracycline-Related Cardiotoxicity · Saro H. Armenian · 2018 · 157 citations · Cited by this paper
  30. Germline genetic polymorphisms may influence chemotherapy response and disease outcome in osteosarcoma · Rachael E. Windsor · 2011 · 147 citations · Cited by this paper
  31. Anthracycline-induced cardiomyopathy · Deborah Lynn Keefe · 2001 · 135 citations · Cited by this paper
  32. Genetic susceptibility to anthracycline‐related congestive heart failure in survivors of haematopoietic cell transplantation · Saro H. Armenian · 2013 · 128 citations · Cited by this paper
  33. Anthracycline-induced cardiotoxicity — are we about to clear this hurdle? · Wolfram C. M. Dempke · 2023 · 128 citations · Cited by this paper
  34. Genetic Variants in SLC22A17 and SLC22A7 are Associated With Anthracycline-Induced Cardiotoxicity in Children · Henk Visscher · 2015 · 123 citations · Cited by this paper
  35. ABCC1 polymorphisms in anthracycline‐induced cardiotoxicity in childhood acute lymphoblastic leukaemia · Ágnes F. Semsei · 2011 · 114 citations · Cited by this paper
  36. Single Nucleotide Polymorphisms of Gemcitabine Metabolic Genes and Pancreatic Cancer Survival and Drug Toxicity · Taro Okazaki · 2009 · 101 citations · Cited by this paper
  37. Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients · Christof Vulsteke · 2015 · 78 citations · Cited by this paper
  38. Evidence for Association of SNPs in ABCB1 and CBR3 , but not RAC2, NCF4, SLC28A3 or TOP2B , with Chronic Cardiotoxicity in a Cohort of Breast Cancer Patients Treated with Anthracyclines · Daniel L. Hertz · 2016 · 77 citations · Cited by this paper
  39. A discovery study of daunorubicin induced cardiotoxicity in a sample of acute myeloid leukemia patients prioritizes P450 oxidoreductase polymorphisms as a potential risk factor · Joanna M. Lubieniecka · 2013 · 69 citations · Cited by this paper

Source: OpenAlex (CC0)